Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus

Endocrinology and Metabolism Clinics of North America

Volumn 30, Issue 4, 2001, Pages 983-997

  Taylor, A A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL TONE; CORONARY RISK; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0035170133     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70223-1     Document Type: Article

References (108)

1. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
2. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease
3. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes
4. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes
5. ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria
6. Nitric oxide inhibits the formation of advanced glycation end products
7. Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics
8. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
9. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans
10. Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome
11. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT
12. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
13. Relationship between autonomic dysfunction and BP variability in subjects with diabetes mellitus
14. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes
15. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia
16. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries
17. Role of prostaglandins in hypertension
18. Endothelial dysfunction in arterial hypertension
19. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
20. Effects of blood pressure and glucose on endothelial function
21. Beta-carotene vitamin C and vitamin E and cardiovascular diseases
22. Hypertension in obesity and NIDDM: Role of insulin and sympathetic nervous system
23. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29
24. Endothelial dysfunction in diabetes
25. Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization (the Balloon Angioplasty Revascularization Investigation)
26. Stroke risk from multiple risk factors combined with hypertension: A primary care based case-controlled study in a defined population in Northwest England
27. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: Blunted vasoconstriction in patients with microalbuminuria
28. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared to healthy subjects
29. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study
30. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
31. Endothelium-derived hyperpolarizing factor
32. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis
33. Early impairment of large artery structure and function in type 1 diabetes mellitus
34. Oxidative stress and diabetic vascular complications
35. Association between wall shear stress and flowmediated vasodilation in healthy men
36. Increased superoxide anion formation in endothelial cells during hyperglycemia: An adaptive response or initial step of vascular dysfunction?
37. NAD(P)H oxidase: Role in cardiovascular biology and disease
38. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
39. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
40. Effects of blood pressure control on progressive renal disease in blacks and whites: Modification of Diet in Renal Disease Study Group
41. Increased forearm blood flow during glucose clamp is related neither to insulin sensitivity nor to hyperinsulinemia in borderline hypertensive young men
42. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
43. Endothelin: Emerging role in diabetic vascular complications
44. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries
45. HDS 2: Increased risk of cardio-vascular complications in hypertensive type 2 diabetic patients
46. HDS 1: Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
47. Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits
48. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
49. Risk factors that attenuate the female coronary disease advantage
50. The Framingham Study: Its 50-year legacy and future promise
51. Noninvasive determination of age-related changes in the human arterial pulse
52. Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type 2 diabetes
53. End-stage renal disease in African-American and white men: 16-Year MRFIT findings
54. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
55. Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
56. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension: Bosentan Hypertension Investigators
57. Aortic distensibility and structural changes in sinoaortic-denervated rats
58. Insulin resistance and its treatment by thiazolidinediones
59. Role of angiotensin II in diabetic nephropathy
60. Arterial wall compliance in diabetes
61. Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance
62. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol
63. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: Blunted response in essential hypertension
64. Arterial distensibility in cardiovascular diseases
65. Do reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients?
66. Angiotensin converting enzyme inhibition and arterial endothelial function in adults with type 1 diabetes mellitus
67. Inhibitory effects of low density lipoproteins from men with type 2 diabetes on endothelium-dependent relaxation
68. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
69. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy
70. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: A randomized, double-blind study
71. The physiology and pathophysiology of the nitric type 2 diabetes on endothelium-dependent relaxation
72. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus
73. A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension
74. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus
75. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
76. Influence of non-insulin-dependent diabetes mellitus on plasma endothelin- 1 levels in patients with advanced atherosclerosis
77. Hypertension and cardiovascular risk factors: Role of the angiotensin II-nitric oxide interaction
78. The metabolic syndrome and related cardiovascular risk
79. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: Parallels between human disease and rodent models
80. Atherosclerosis-an inflammatory disease
81. Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine
82. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: The ARIC Study
83. Reactive oxygen species and the control of vasomotor tone
84. Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans
85. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
86. Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: Beneficial effects of cicletanine
87. Elevated plasma endothelin in patients with diabetes mellitus
88. Diabetes mellitus abolishes ethnic differences in cardiovascular risk factors: Lessons from a multi-ethnic population
89. Human coronary arteriolar dilation to adrenomedullin: Role of nitric oxide and K(+) channels
90. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C
91. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta
92. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
93. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta
94. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
95. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
96. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia
97. Relation of obesity and diet to sympathetic nervous system activity
98. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
99. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT)
100. Vascular endothelium: Vasoactive mediators
101. Effect of endothelin-1 in man
102. Apolipoprotein (b) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients
103. Putative determinants of arterial wall compliance in NIDDM
104. Atherosclerosis and the two faces of endothelial nitric oxide synthase
105. Increased augmentation index and systolic stress in type 1 diabetes mellitus
106. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
107. Linical predictors of morbidity and mortality in patients with myocardial infarction or revascularization who underwent cardiac rehabilitation, and importance of diabetes mellitus and exercise capacity
108. Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators